Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025

GlobeNewswireMay 15 20:30

Jyong Biotech | 20-F: Registration statement / Annual report / Transition report

SECMay 15 18:14 · Announcements

Jyong Biotech Delays Annual 20-F (Yearly Report)

TipRanksApr 30 02:19

Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio

GlobeNewswireApr 28 20:30

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS-2

GlobeNewswireMar 27 20:30

12 Health Care Stocks Moving In Wednesday's After-Market Session

BenzingaFeb 26 05:07